{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:03:38Z","timestamp":1779678218465,"version":"3.53.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the General Guidance Project of Guangzhou Municipal Health Commission","award":["20251A011017"],"award-info":[{"award-number":["20251A011017"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270400"],"award-info":[{"award-number":["82270400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Guangdong Province","award":["2023A1515010731"],"award-info":[{"award-number":["2023A1515010731"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202411021"],"award-info":[{"award-number":["SZSM202411021"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02263-5","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:45:24Z","timestamp":1776249924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of herpes zoster and post-zoster SGLT2 inhibitors initiation on cardiorenal outcomes in type 2 diabetes mellitus"],"prefix":"10.1186","volume":"26","author":[{"given":"Mei-zhen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Tze-Wei","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Kei","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yap-Hang","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-wen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hang","family":"Yiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2263_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"20","key":"2263_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despr\u00e9s JP, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"key":"2263_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.puhe.2018.10.015","volume":"167","author":"M Mareque","year":"2019","unstructured":"Mareque M, Oyag\u00fcez I, Morano R, Casado MA. Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain. Public Health. 2019;167:136\u201346.","journal-title":"Public Health"},{"issue":"16","key":"2263_CR4","doi-asserted-by":"publisher","first-page":"e25292","DOI":"10.1097\/MD.0000000000025292","volume":"100","author":"SW Lai","year":"2021","unstructured":"Lai SW, Liu CS, Kuo YH, Lin CL, Hwang BF, Liao KF. The incidence of herpes zoster in patients with diabetes mellitus: A meta-analysis of cohort studies. Med (Baltim). 2021;100(16):e25292.","journal-title":"Med (Baltim)"},{"issue":"11","key":"2263_CR5","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.2337\/dc21-2053","volume":"45","author":"JE Poirrier","year":"2022","unstructured":"Poirrier JE, Meyers JL, Nagar SP, Patterson BJ, Glasser LI, Jabbour SA. Herpes Zoster Incidence and Burden in Adults With Type 2 Diabetes in the U.S.: A Retrospective Database Analysis. Diabetes Care. 2022;45(11):2585\u201393.","journal-title":"Diabetes Care"},{"issue":"20","key":"2263_CR6","doi-asserted-by":"publisher","first-page":"e013389","DOI":"10.1161\/JAHA.119.013389","volume":"8","author":"CSP Lam","year":"2019","unstructured":"Lam CSP, Chandramouli C, Ahooja V, Verma S. SGLT-2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects. J Am Heart Assoc. 2019;8(20):e013389.","journal-title":"J Am Heart Assoc"},{"key":"2263_CR7","unstructured":"The Hospital Authority. Hospital authority statistical report. 2021\u20132022."},{"issue":"11","key":"2263_CR8","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1136\/gutjnl-2018-317714","volume":"68","author":"KS Cheung","year":"2019","unstructured":"Cheung KS, Chen L, Chan EW, Seto WK, Wong ICK, Leung WK. Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187 897 patients. Gut. 2019;68(11):1979\u201385.","journal-title":"Gut"},{"issue":"3","key":"2263_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","volume":"149","author":"EW Chan","year":"2015","unstructured":"Chan EW, Lau WC, Leung WK, Mok MT, He Y, Tong TS, Wong IC. Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study. Gastroenterology. 2015;149(3):586\u2013e595583.","journal-title":"Gastroenterology"},{"issue":"1","key":"2263_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2337\/dc22-1188","volume":"46","author":"JY Huang","year":"2023","unstructured":"Huang JY, Tse YK, Li HL, Chen C, Zhao CT, Liu MY, Wu MZ, Ren QW, Yu SY, Hung D, et al. Prediabetes is associated with increased risk of heart failure among patients with atrial fibrillation. Diabetes Care. 2023;46(1):190\u20136.","journal-title":"Diabetes Care"},{"key":"2263_CR11","doi-asserted-by":"crossref","unstructured":"Ren Q-W, Yu S-Y, Teng T-HK, Li X, Cheung K-S, Wu M-Z, Li H-L, Wong P-F, Tse H-F, Lam CSP, et al. Statin associated lower cancer risk and related mortality in patients with heart failure. Eur Heart J. 2021;42(32):3049-59.","DOI":"10.1093\/eurheartj\/ehab325"},{"key":"2263_CR12","doi-asserted-by":"crossref","unstructured":"Wu MZ, Guo R, Chandramouli C, Liu L, Tung AM, Tsang CT, Tse YK, Chan YH, Lee CH, Huang JY, et al. Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients. Eur Heart J. 2025.","DOI":"10.1093\/eurheartj\/ehaf788"},{"key":"2263_CR13","doi-asserted-by":"crossref","unstructured":"Ramos R, Comas-Cuf\u00ed M, Mart\u00ed-Lluch R, Ball\u00f3 E, Ponjoan A, Alves-Cabratosa L, Blanch J, Marrugat J, Elosua R, Grau M. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. bmj. 2018;362:k3359.","DOI":"10.1136\/bmj.k3359"},{"issue":"10","key":"2263_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/aje\/kwi307","volume":"162","author":"Z Zhou","year":"2005","unstructured":"Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival Bias Associated with Time-to-Treatment Initiation in Drug Effectiveness Evaluation: A Comparison of Methods. Am J Epidemiol. 2005;162(10):1016\u201323.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2263_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1053\/j.gastro.2015.10.007","volume":"150","author":"A Mohanty","year":"2016","unstructured":"Mohanty A, Tate JP, Garcia-Tsao G. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. Gastroenterology. 2016;150(2):430\u201340.e1.","journal-title":"Gastroenterology"},{"key":"2263_CR16","unstructured":"Organization WH. The Asia-Pacific perspective: redefining obesity and its treatment. 2000;17\u201320."},{"key":"2263_CR17","doi-asserted-by":"crossref","unstructured":"Imai K, Ratkovic M. Covariate balancing propensity score. J Royal Stat Society: Ser B: Stat Methodol 2014:243\u201363.","DOI":"10.1111\/rssb.12027"},{"issue":"2","key":"2263_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2024.10.091","volume":"85","author":"FRM Causland","year":"2025","unstructured":"Causland FRM, Vaduganathan M, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Henderson AD, Brinker M, Perkins R, Scheerer MF, et al. Finerenone and Kidney Outcomes in Patients With Heart Failure. JACC. 2025;85(2):159\u201368.","journal-title":"JACC"},{"issue":"2","key":"2263_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248\u201360.","journal-title":"Kidney Int"},{"issue":"5","key":"2263_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2337\/dc15-2322","volume":"39","author":"MG Wong","year":"2016","unstructured":"Wong MG, Perkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, MacMahon S, et al. Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. Diabetes Care. 2016;39(5):694\u2013700.","journal-title":"Diabetes Care"},{"issue":"4","key":"2263_CR21","doi-asserted-by":"publisher","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","volume":"312","author":"R Pichler","year":"2017","unstructured":"Pichler R, Afkarian M, Dieter BP, Tuttle KR. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Ren Physiol. 2017;312(4):F716\u201331.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"11","key":"2263_CR22","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.2337\/dc22-0866","volume":"45","author":"A Koshino","year":"2022","unstructured":"Koshino A, Schechter M, Sen T, Vart P, Neuen BL, Neal B, Arnott C, Perkovic V, Ridker PM, Tuttle KR, et al. Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS. Diabetes Care. 2022;45(11):2644\u201352.","journal-title":"Diabetes Care"},{"issue":"1","key":"2263_CR23","doi-asserted-by":"publisher","first-page":"2344983","DOI":"10.1080\/21645515.2024.2344983","volume":"20","author":"J Chen","year":"2024","unstructured":"Chen J, Abrahamson PE, Ke Y, Ong CR, Parikh R, Shantakumar S. A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific. Hum Vaccin Immunother. 2024;20(1):2344983.","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"2263_CR24","doi-asserted-by":"publisher","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","volume":"73","author":"RR Thompson","year":"2021","unstructured":"Thompson RR, Kong CL, Porco TC, Kim E, Ebert CD, Acharya NR. Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States. Clin Infect Dis. 2021;73(9):e3210\u20137.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2263_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/jmv.23892","volume":"86","author":"PY Wu","year":"2014","unstructured":"Wu PY, Lin CL, Sung FC, Chou TC, Lee YT. Increased risk of cardiovascular events in patients with herpes zoster: a population-based study. J Med Virol. 2014;86(5):772\u20137.","journal-title":"J Med Virol"},{"issue":"3","key":"2263_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0000000000000038","volume":"82","author":"J Breuer","year":"2014","unstructured":"Breuer J, Pacou M, Gauthier A, Brown MM. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;82(3):206\u201312.","journal-title":"Neurology"},{"issue":"23","key":"2263_CR27","doi-asserted-by":"publisher","first-page":"e027451","DOI":"10.1161\/JAHA.122.027451","volume":"11","author":"SG Curhan","year":"2022","unstructured":"Curhan SG, Kawai K, Yawn B, Rexrode KM, Rimm EB, Curhan GC. Herpes Zoster and Long-Term Risk of Cardiovascular Disease. J Am Heart Assoc. 2022;11(23):e027451.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"2263_CR28","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s10096-014-2143-6","volume":"33","author":"SY Lin","year":"2014","unstructured":"Lin SY, Liu JH, Yeh HC, Lin CL, Tsai IJ, Chen PC, Sung FC, Yang YF, Huang CC, Morisky DE, et al. Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: a population-based cohort study. Eur J Clin Microbiol Infect Dis. 2014;33(10):1809\u201315.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"2263_CR29","doi-asserted-by":"publisher","first-page":"e1001919","DOI":"10.1371\/journal.pmed.1001919","volume":"12","author":"C Minassian","year":"2015","unstructured":"Minassian C, Thomas SL, Smeeth L, Douglas I, Brauer R, Langan SM. Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. PLoS Med. 2015;12(12):e1001919.","journal-title":"PLoS Med"},{"issue":"12","key":"2263_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrneurol.2010.163","volume":"6","author":"AJ Grau","year":"2010","unstructured":"Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Reviews Neurol. 2010;6(12):681\u201394.","journal-title":"Nat Reviews Neurol"},{"issue":"5","key":"2263_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/MOH.0b013e328364219d","volume":"20","author":"P Nagareddy","year":"2013","unstructured":"Nagareddy P, Smyth SS. Inflammation and thrombosis in cardiovascular disease. Curr Opin Hematol. 2013;20(5):457\u201363.","journal-title":"Curr Opin Hematol"},{"issue":"8","key":"2263_CR32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 2009;8(8):731\u201340.","journal-title":"Lancet Neurol"},{"key":"2263_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2017.03.014","volume":"308","author":"MA Nagel","year":"2017","unstructured":"Nagel MA, Jones D, Wyborny A. Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis. J Neuroimmunol. 2017;308:112\u20137.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"2263_CR34","doi-asserted-by":"publisher","first-page":"e023811","DOI":"10.1161\/JAHA.121.023811","volume":"11","author":"R Adhikari","year":"2022","unstructured":"Adhikari R, Jha K, Dardari Z, Heyward J, Blumenthal RS, Eckel RH, Alexander GC, Blaha MJ. National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020. J Am Heart Assoc. 2022;11(9):e023811.","journal-title":"J Am Heart Assoc"},{"key":"2263_CR35","doi-asserted-by":"publisher","first-page":"e080925","DOI":"10.1136\/bmj-2024-080925","volume":"387","author":"H Svanstr\u00f6m","year":"2024","unstructured":"Svanstr\u00f6m H, Mkoma GF, Hviid A, Pasternak B. SGLT-2 inhibitors and mortality among patients with heart failure with reduced ejection fraction: linked database study. BMJ. 2024;387:e080925.","journal-title":"BMJ"},{"issue":"11","key":"2263_CR36","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.2337\/dc20-1890","volume":"43","author":"Y Xie","year":"2020","unstructured":"Xie Y, Bowe B, Gibson AK, McGill JB, Maddukuri G, Yan Y, Al-Aly Z. Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases. Diabetes Care. 2020;43(11):2859\u201369.","journal-title":"Diabetes Care"},{"issue":"22","key":"2263_CR37","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"4","key":"2263_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019;380(4):347\u201357.","journal-title":"N Engl J Med"},{"issue":"5","key":"2263_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/cvr\/cvae047","volume":"120","author":"A Preda","year":"2024","unstructured":"Preda A, Montecucco F, Carbone F, Camici GG, L\u00fcscher TF, Kraler S, Liberale L. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits. Cardiovasc Res. 2024;120(5):443\u201360.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"2263_CR40","doi-asserted-by":"publisher","first-page":"C525","DOI":"10.1152\/ajpcell.00143.2024","volume":"327","author":"ACC Girardi","year":"2024","unstructured":"Girardi ACC, Polidoro JZ, Castro PC, Pio-Abreu A, Noronha IL, Drager LF. Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions. Am J Physiology-Cell Physiol. 2024;327(3):C525\u201344.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"22","key":"2263_CR41","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barber\u00e0 J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087\u201396.","journal-title":"N Engl J Med"},{"issue":"10","key":"2263_CR42","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00592-023-02127-7","volume":"60","author":"GA Silverii","year":"2023","unstructured":"Silverii GA, Clerico A, Fornengo R, Gabutti G, Sordi V, Peruzzi O, Tafuri S, Mannucci E, Dicembrini I. Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies. Acta Diabetol. 2023;60(10):1343\u20139.","journal-title":"Acta Diabetol"},{"issue":"2","key":"2263_CR43","doi-asserted-by":"publisher","first-page":"e090428","DOI":"10.1136\/bmjopen-2024-090428","volume":"15","author":"E Kornelius","year":"2025","unstructured":"Kornelius E, Lo SC, Huang CN, Wang CC, Wang YH, Yang YS. Association of herpes zoster vaccination and cardiovascular risk in patients with diabetes: long-term insights from a retrospective cohort study. BMJ Open. 2025;15(2):e090428.","journal-title":"BMJ Open"},{"issue":"2","key":"2263_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/infdis\/jiaf105","volume":"232","author":"X Xu","year":"2025","unstructured":"Xu X, Ray I, Tang E, Arnold BF, Acharya NR. Protective Effects of Recombinant Zoster Vaccine and Antiviral Therapy Against Cardiovascular Disease Following Herpes Zoster Infection. J Infect Dis. 2025;232(2):465\u201373.","journal-title":"J Infect Dis"},{"key":"2263_CR45","doi-asserted-by":"publisher","first-page":"1606679","DOI":"10.3389\/phrs.2024.1606679","volume":"45","author":"X Wang","year":"2024","unstructured":"Wang X, Shang S, Zhang E, Dai Z, Xing Y, Hu J, Gao Y, Fang Q. Unraveling Herpes Zoster Vaccine Hesitancy, Acceptance, and Its Predictors: Insights From a Scoping Review. Public Health Rev. 2024;45:1606679.","journal-title":"Public Health Rev"},{"key":"2263_CR46","unstructured":"CDC. What Everyone Should Know about the Shingles Vaccine (Shingrix). 2023."},{"issue":"3","key":"2263_CR47","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146\u2013156.","journal-title":"J Gerontol Biol Sci Med Sci"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02263-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:31:00Z","timestamp":1779676260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02263-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02263-5","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the University of Hong Kong and the West Cluster of the Hong Kong Hospital Authority (IRB Ref. No.: UW 24\u2013679). Given the retrospective nature of the study, the requirement for informed consent was waived by the ethics committee in accordance with relevant laws and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}